Skip to content

PERFECT Project - Part 2 - Study 1

Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 2 - Acute Effects of Pulse Ingredients in Food Products on Aerobic Endurance and Substrate Oxidation During Exercise, as Well as, the Blood Glucose, Insulin, Lactate and Food Intake Response Following an Endurance Exercise Session in Adults - Study 1

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02402517
Enrollment
30
Registered
2015-03-30
Start date
2015-08-31
Completion date
2017-12-31
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Obesity

Keywords

Diabetes Prevention, Obesity Prevention

Brief summary

The objectives are to test the acute effects of different extruded pulse snacks on: 1) aerobic endurance and substrate oxidation during exercise 2) response of blood glucose, insulin and appetite on an aerobic exercise session, and 3) food intake two hours following the exercise session. The investigators hypothesize that consumption of food products containing pulse ingredients 60 minutes before exercise will increase aerobic endurance (lower oxygen consumption), decrease carbohydrate oxidation (greater respiratory quotient), and a reduction in lactate production during compared to the same exercise session following the ingestion of a non-pulse food. The investigators also hypothesize that consumption of extruded pulse snacks will lead to lower blood glucose, insulin, appetite and food intake, suggesting lower calorie compensation, following a 60-minute aerobic exercise session compared to the same exercise session following the ingestion of a non-pulse food.

Interventions

OTHERControl

Non pulse extruded snack

Pulse extruded snack

Pulse extruded snack

Pulse extruded snack

Pulse extruded snack

Pulse extruded snack

Sponsors

Saskatchewan Pulse Growers
CollaboratorOTHER
Alberta Pulse Growers
CollaboratorOTHER
University of Manitoba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Normoglycemic (\<5.6 mmol/L) and normotensive (systolic blood pressure \<140 mm Hg and diastolic blood pressure below \< 90 mm Hg) * BMI of 18.5-29.9 kg/m2

Exclusion criteria

* Restrained eaters * Regularly skip breakfast * Smokers * Those who are active (organized activities or athletic training at a high intensity; ≥ 150 min per week of moderate to vigorous physical activity) * Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year. * Those unable to walk for an hour continuously

Design outcomes

Primary

MeasureTime frameDescription
Plasma Glucose and Insulin Concentrations0 - 240 minMeasured in blood using intravenous catheter at 14 time points, used to calculate area under curve (AUC). Glucose will be determined by automated methods using Abbot Spectrum CCX Analyzer, and Insulin will be measured by commercially available RIA kits. (Composite measure)
Food Intakeat 120 minAd-libitum meal. Food consumed measured by weight.
Subjective Appetite0-240 minMeasured by VAS questionnaire at 14 time points, used to calculate area under curve (AUC).( Composite measure)
Exercise intensity60 minutesSixty minute exercise protocol at minutes 60 to 120. Oxygen consumption measured during exercise at 3 time points.

Secondary

MeasureTime frameDescription
Energy/fatigue0-240 minMeasured by VAS questionnaire at 13 time points, used to calculate area under curve (AUC) (Composite measure)
Lactate concentration60 minutes60 minute exercise protocol at minutes 60 to 120. Measured before, during, and exercise exercise at 3 time points
Substrate Oxidation60 minutesMeasured during 60 minute exercise protocol at minutes 60-120. Respiratory quotient measured during exercise at 3 time points.
Heart rate60-120 minHeart rate monitored over a 60 minute exercise protocol. To monitor exercise intensity and give a measure of fatigue (cardiovascular drift)
Palatability of treatmentsat 5 minutesMeasured by VAS questionnaire
Palatability of mealat 260 minutesMeasured by VAS questionnaire
Physical comfort0-240 minMeasured by VAS questionnaire at 13 time points, used to calculate area under curve (AUC) (Composite measure)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026